First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers
Angevin, Eric, Isambert, Nicolas, Trillet-Lenoir, Véronique, You, Benoit, Alexandre, Jérôme, Zalcman, Gérard, Vielh, Philippe, Farace, Françoise, Valleix, Fanny, Podoll, Thomas, Kuramochi, Yu, MiyashiТом:
116
Мова:
english
Журнал:
British Journal of Cancer
DOI:
10.1038/bjc.2017.62
Date:
April, 2017
Файл:
PDF, 675 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
